Tissue repair mechanisms: Accelerated wound healing (corneal defects closing faster than typical)
Tirzepatide, which acts on both GLP-1 and GIP receptors, generally produces greater weight loss in clinical trials compared to semaglutide alone
If it is deemed appropriate, the professional will provide a prescription
Single GLP-1 agonism (the semaglutide model) drives appetite suppression and glucose control but plateaus in how much weight it can shift
in: PubMed | Google Scholar | 1 Department of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel
Even with the discount, the $499 price point remains out of reach for many patients